Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
OverC™
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Burning Rock Biotech
Type:
CE Marked
Related tests:
‹
OncoCompass™ Target (1)
LungCure™ CDx
OncoScreen Plus®
OncoScreen™ Focus CDx Tissue Kit
OncoScreen™ IO
OncoCompass™ Target (1)
LungCure™ CDx
OncoScreen Plus®
OncoScreen™ Focus CDx Tissue Kit
OncoScreen™ IO
›
Details
Evidence
News
Search handles
Search handles
Filter by
Latest
1year
The FDA has granted a breakthrough device designation to the OverC Multi-Cancer Detection Blood Test (MCDBT) for the early detection of cancers including esophageal, liver, lung, ovarian, and pancreatic in 50 - 75 y/o with average risk https://t.co/lP4vcWOLZH via @onclive ()
1 year ago
FDA event
|
OverC™
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login